FIELD: chemistry.
SUBSTANCE: invention relates to substituted extratriene derivatives of general formula 
(values of radicals are given in the claim), useful in therapy, especially for treating and/or preventing steroid hormone-dependent disorders which require inhibition of 17β-hydroxysteroid dehydrogenase (17-HSD) enzyme type 1, type 2 and/or type 3, as well as salts thereof, pharmaceutical preparations containing said compounds, as well as methods of producing said compounds.
EFFECT: improved method.
41 cl, 98 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 17β-HSD1 AND STS INHIBITORS | 2006 |
|
RU2412196C2 |
| NEW INHIBITORS OF 17 β-HYDROXYSTEROID-DEHYDROGENASE TYPE I | 2004 |
|
RU2369614C2 |
| THERAPEUTICALLY ACTIVE TRIAZOLES AND USE THEREOF | 2007 |
|
RU2469042C2 |
| DERIVATIVES OF 16-HYDROXY-11-(SUBSTITUTED PHENYL)-ESTRA-4,9-DIENE, COMPOUND, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2187510C2 |
| BENZOPIPERIDINE DERIVATIVES, BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1992 |
|
RU2142945C1 |
| 17α-ALKYL-17β-HYDROXYESTRATRIENES, THEIR USING AND PHARMACEUTICAL PREPARATION | 2002 |
|
RU2285009C2 |
| PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR CANCER TREATMENT | 2013 |
|
RU2672916C2 |
| 17 β -OXYESTRATRIENES | 2002 |
|
RU2339643C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE | 1995 |
|
RU2179442C2 |
| NOVEL COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2412190C2 |
